Compare MVSTW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MVSTW | RLAY |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | United States |
| Employees | 1908 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 2.5B |
| IPO Year | N/A | 2020 |
| Metric | MVSTW | RLAY |
|---|---|---|
| Price | $0.01 | $13.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $19.50 |
| AVG Volume (30 Days) | 171.4K | ★ 4.3M |
| Earning Date | 03-14-2025 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $370,989,000.00 | $15,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $324.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 39.03 | ★ 53.44 |
| 52 Week Low | $0.01 | $2.98 |
| 52 Week High | $0.65 | $17.47 |
| Indicator | MVSTW | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 33.66 | 45.85 |
| Support Level | $0.01 | $11.68 |
| Resistance Level | $0.07 | $15.45 |
| Average True Range (ATR) | 0.00 | 1.24 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 7.14 | 25.81 |
Microvast Holdings Inc develops lithium-ion battery technologies focused on high-performance solutions for commercial and industrial electrification. The Company designs, develops, and manufactures battery components and systems for electric commercial vehicles and energy storage systems (ESS), with applications across buses, trucks, port equipment, and mining machinery. It emphasizes innovation in battery design without relying on legacy technologies and supports platforms such as the IVECO eDaily and various bus models. The Company also provides services, repairs, and warranty and extended warranty support. It operates as a single reportable segment, covering design, development, manufacturing, sales, and leasing of battery systems, and generates the majority of its revenue from Europe.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.